MS - Morgan Stanley
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$239.50
DETAILS
HIGH:
$260.00
LOW:
$215.00
MEDIAN:
$241.50
CONSENSUS:
$239.50
UPSIDE:
10.64%
AlphaVal
Deterministic, archetype-aware fair value
Banks, Insurers & Asset Managers
90% confidence
Primary model: P/Tangible Book × ROE Quality
Adjust Assumptions
19.0%
10.9%
Key Value Driver
ROTCE (19.0%) vs. cost of equity (10.9%)
Implied Market Multiple
3.84x
Plain-Language Summary
With ROTCE of 19.0% vs. 10.9% cost of equity, fair P/TBV is 2.15x on $56.36 tangible book, implying $206.70 per share. DDM cross-check: $134.03.
Analyst Consensus (External Reference)
Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.
Average Target (52 analysts)
$239.50
Analyst Range
$215.00 – $260.00
Divergence from AlphaVal
14%
Warnings
Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Dividend-based valuation: $134.03 (35% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.
Key Risks
- Book value quality matters as much as level — check loan loss reserves
- Interest rate sensitivity creates non-linear earnings surprises
- Insurance reserving is actuarial, not financial — errors emerge slowly